Compare LTRN & BIRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LTRN | BIRD |
|---|---|---|
| Founded | 2013 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.2M | 26.2M |
| IPO Year | 2020 | 2021 |
| Metric | LTRN | BIRD |
|---|---|---|
| Price | $2.15 | $6.40 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 315.7K | ★ 14.0M |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 18.65 | ★ 20.22 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $152,466,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $35.12 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.11 | $2.15 |
| 52 Week High | $5.74 | $24.31 |
| Indicator | LTRN | BIRD |
|---|---|---|
| Relative Strength Index (RSI) | 45.48 | 50.98 |
| Support Level | $1.11 | $4.24 |
| Resistance Level | $2.41 | $9.87 |
| Average True Range (ATR) | 0.32 | 2.59 |
| MACD | -0.03 | -0.32 |
| Stochastic Oscillator | 15.12 | 18.34 |
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.
Allbirds Inc is a lifestyle brand that innovates with naturally derived materials to make footwear and apparel products in a better way, while treading lighter on the planet. Its primary source of revenue is from sales of shoes and apparel products. The majority of the revenue is derived from United States.